These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9183728)

  • 21. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valve-related complications with the Hancock I porcine bioprosthesis. A twelve- to fourteen-year follow-up study.
    Bernal JM; Rabasa JM; Cagigas JC; Echevarria JR; Carrion MF; Revuelta JM
    J Thorac Cardiovasc Surg; 1991 May; 101(5):871-80. PubMed ID: 2023444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes.
    Murashita T; Sugiki H; Kamikubo Y; Yasuda K
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1104-11. PubMed ID: 15541970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porcine stentless aortic valve in re-replacements and acute aortic valve endocarditis.
    Gontijo BF; Vrandecic M; Fantini FA; Oliveira MH; Avelar SO
    J Heart Valve Dis; 1995 Mar; 4(2):171-5. PubMed ID: 8556178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periprosthetic leakage after aortic valve replacement.
    Varstela E; Verkkala K; Turto H
    Ann Chir Gynaecol; 1994; 83(3):210-7. PubMed ID: 7857065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of double valve surgery for active infective endocarditis.
    Sheikh AM; Elhenawy AM; Maganti M; Armstrong S; David TE; Feindel CM
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):69-75. PubMed ID: 19577059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morbidity and mortality seen in patients with a Hancock bioprosthesis, followed for more than 5 years. Experience at the La Pitié Hospital].
    Jault F; Gandjbakhch I; Pavie A; Fontanel M; Bors V; Cabrol C
    Arch Mal Coeur Vaiss; 1988 Jan; 81(1):49-54. PubMed ID: 3130021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reoperation on valve bioprostheses. Apropos of 64 cases].
    Donzeau-Gouge GP; Benomar M; Chauvaud S; Nottin R; Fabiani JN; Farge C; Gorny P; Deloche A; d'Allaines C; Blondeau P
    Arch Mal Coeur Vaiss; 1985 Aug; 78(8):1210-15. PubMed ID: 3935079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early outcome after surgery for active native and prosthetic aortic valve endocarditis.
    Gabbieri D; Dohmen PM; Linneweber J; Grubitzsch H; von Heymann C; Neumann K; Halle E; Konertz WF
    J Heart Valve Dis; 2008 Sep; 17(5):508-24; discussion 525. PubMed ID: 18980085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and management of endocarditis after mitral valve repair.
    Karavas AN; Filsoufi F; Mihaljevic T; Aranki SF; Cohn LH; Byrne JG
    J Heart Valve Dis; 2002 Sep; 11(5):660-4. PubMed ID: 12358402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Medtronic Intact porcine bioprosthesis: clinical performance to eight years.
    Munro AI; Jamieson WR; Tyers GF; Burr LH
    J Heart Valve Dis; 1994 Nov; 3(6):634-40. PubMed ID: 8000606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recurrent ejection of aortic valve prostheses. Apropos of 22 case reports].
    Bensaid J; Gandjbakhch I; Dewilde J; Bassand JP; Pornin M; Ourbak P; Pony JC; Logeais Y; Acar J; Gerbaux A; Cabrol C; Maurice P
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):123-31. PubMed ID: 6407420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications with glutaraldehyde-preseved bioprostheses.
    Wright JS; Newman DC
    Med J Aust; 1980 May; 1(11):542-3. PubMed ID: 7393038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortic valve replacement with stentless porcine aortic valves: a ten-year experience.
    David TE; Feindel CM; Scully HE; Bos J; Rakowski H
    J Heart Valve Dis; 1998 May; 7(3):250-4. PubMed ID: 9651835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis.
    Fedoruk LM; Jamieson WR; Ling H; Macnab JS; Germann E; Karim SS; Lichtenstein SV
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):326-33. PubMed ID: 19185146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic findings in explanted Hancock II porcine bioprostheses.
    Butany J; Yu W; Silver MD; David TE
    J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology of the Pericarbon bovine pericardial xenograft implanted in humans.
    Valente M; Ius P; Bortolotti U; Talenti E; Bottio T; Thiene G
    J Heart Valve Dis; 1998 Mar; 7(2):180-9. PubMed ID: 9587859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with the Carpentier-Edwards porcine xenograft.
    Jamieson MP; Bennett JG; Robles A; Ross DN
    Thorac Cardiovasc Surg; 1981 Aug; 29(4):200-5. PubMed ID: 6179185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.